Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by unclebobieon Dec 19, 2018 4:25pm
88 Views
Post# 29137104

insider sales ouch

insider sales ouch
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
06. Oct 18 Sell Michael Singer Individual     03. Oct 18 04. Oct 18 -115,428 CA$12.16 CA$-1,169,525
02. Oct 18 Sell Diane Jang Individual     28. Sep 18 28. Sep 18 -14,134 CA$12.32 CA$-173,735
17. Aug 18 Buy Allan Cleiren Individual     17. Aug 18 17. Aug 18 39,600 CA$6.36 CA$251,828
27. Jul 18 Sell Stephen Dobler Individual     24. Jul 18 24. Jul 18 -1,386,100 CA$7.70 CA$-10,672,970
15. May 18 Sell Jason Ronald Dyck Individual     29. Dec 17 29. Dec 17 -379,215 CA$9.99 CA$-3,788,358
04. May 18 Sell Adam Szweras Individual     12. Mar 18 12. Mar 18 -200,000 CA$11.42 CA$-2,283,840
10. Apr 18 Buy Jason Ronald Dyck Individual     09. Apr 18 09. Apr 18 25,500 CA$7.80 CA$198,900
07. Apr 18 Buy Glen Ibbott Individual     02. Apr 18 02. Apr 18 20,000 CA$8.78 CA$175,600
29. Mar 18 Buy Ronan Levy Individual     28. Mar 18 28. Mar 18 27,000 CA$9.19 CA$248,130
29. Mar 18 Buy Cameron Battley Individual     28. Mar 18 28. Mar 18 27,685 CA$9.04 CA$250,217
19. Mar 18 Sell Dale Lesack Individual     12. Mar 18 16. Mar 18 -105,000 CA$11.88 CA$-1,223,950
16. Mar 18 Sell Ronan Levy Individual     13. Mar 18 13. Mar 18 -50,000 CA$11.56 CA$-578,000
16. Mar 18 Sell Neil Belot Individual     12. Mar 18 13. Mar 18 -242,000 CA$11.51 CA$-2,776,166
16. Mar 18 Sell Stephen Dobler Individual     13. Mar 18 13. Mar 18 -900,000 CA$11.54 CA$-10,388,700
16. Mar 18 Sell Terry Booth Individual     13. Mar 18 13. Mar 18 -464,183 CA$11.54 CA$-5,358,064
03. Mar 18 Buy Debra Wilson Individual     28. Feb 18 28. Feb 18 35 CA$10.64 CA$372
23. Feb 18 Sell Nilda Rivera Individual     21. Feb 18 21. Feb 18 -200,000 CA$10.94 CA$-2,188,000
21. Feb 18 Buy Ronan Levy Individual     08. Feb 18 08. Feb 18 5,213 CA$10.51 CA$54,789
15. Feb 18 Buy Debra Wilson Individual     13. Feb 18 13. Feb 18 35 CA$10.68 CA$374
31. Dec 17 Sell Glen Ibbott Individual     28. Dec 17 28. Dec 17 -3,774 CA$8.57 CA$-32,343
27. Dec 17 Buy Glen Ibbott Individual     20. Dec 17 20. Dec 17 10,000 CA$7.03 CA$70,300
X
MANAGEMENT CHECKS
We assess Aurora Cannabis's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Aurora Cannabis has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations. 

Note 2: Insider trading include any internal stakeholders and these transactions 

Full details on the Management part of the Simply Wall St company analysis model.

NWS


Bullboard Posts